Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Japan shares slip for third day; all eyes on U.S. stimulus debate

Published 12/08/2020, 02:42 PM
Updated 12/08/2020, 02:50 PM
© Reuters.

TOKYO, Dec 8 (Reuters) - Japanese shares ended lower for the
third straight session on Tuesday, as a month-long rally ran out
of gas, with investors awaiting U.S. lawmakers' decision on a
fresh COVID-19 pandemic relief package.
The Nikkei share average .N225 lost 0.30% to close at
26,467.08. The broader Topix .TOPX shed 0.11% to 1,758.81,
after touching its lowest since Nov. 20 earlier in the session.
The U.S. Congress will vote this week on a one-week stopgap
funding bill to provide more time for lawmakers to reach a deal
on coronavirus relief and an overarching spending bill to avoid
a government shutdown. Japan will compile a fresh 73.6 trillion yen ($708 billion)
economic stimulus package to speed up the country's recovery
from its deep coronavirus slump, Prime Minister Yoshihide Suga
said. Overall sentiment remained upbeat as investors expect the
global economic recovery to continue, with COVID-19 vaccines
look set to be rolled out soon and stimulate consumption
worldwide.
"The global manufacturing cycle is about to enter an
expansion phase from contraction. For value shares, including a
lot of Japanese shares, that is the phase when they historically
performed the best," said Shusuke Yamada, chief Japan FX and
equity strategist at Bank of America.
Hydrogen product maker Iwatani 8088.T jumped 10.3% after
the Nikkei business daily reported that Japan was likely to set
a target to expand the use of hydrogen to 10 million tonne by
2030 to meet its emission goal. Sekisui House 1928.T rose 4.3% after the housing maker's
earnings beat estimates. Many tech-related shares gained, with Keyence 6861.T
rising 2.1%, while Nintendo 7974.T and Murata Manufacturing
6981.T rising 1.1% and 0.5%, respectively.
Drugmakers underperformed, with Daiichi Sankyo 4568.T and
Astellas Pharma 4503.T losing 3.2% and 2.0%, respectively.
The index of Mothers start-up market .MTHR managed to
bounce back to end 1.4% higher, after briefly falling below its
100-day moving average for the first time since late April.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.